SureTrader
Home > Boards > Free Zone > Penny Trading - Technical > BB's Stock Haven

NeutriSci International (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NetworkNewsWire Member Profile
Member Level 
Followed By 39
Posts 4,041
Boards Moderated 33
Alias Born 10/18/16
160x600 placeholder
NetworkNewsWire Member Level  Friday, 01/12/18 04:19:32 PM
Re: None
Post # of 4284882 
Compensated Awareness Post - View Disclaimer
NeutriSci International (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) Announces a Major R&D MOU with Scientus Pharma to Develop a Medical Cannabinoid Retail Product

Related Press Release

NeutriSci International (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) this morning announced that it has entered into a major research and development (R&D) Memorandum of Understanding (“MOU”) with Scientus Pharma Inc. In accordance of the terms set forth in the MOU, the two companies have agreed to share their technologies to develop, test, produce, and distribute a medical cannabinoid product for current retail distribution networks throughout Canada. "This Scientus Pharma partnership helps position us at the forefront of developing new and innovative cannabinoid based medical products in Canada. Scientus Pharma, along with its existing partnerships, is sure to be a dominant player in the cannabis space in Canada. Through a collaborative effort, we will incorporate NeutriSci’s IP, technology and ingredients with Scientus’ expertise, proprietary technical know-how, and resources. By leveraging both parties existing partnerships, we will be positioned to offer the national retail consumer a safe, effective, dose controlled product that completes our ‘plant to blood stream’ strategy,” NeutriSci president Glen Rehman stated in the news release.

Listen to NetworkNewsAudio

View Original Press Release

About NeutriSci International Inc.

NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on increasing the size of its existing national retail network in Canada by building sustainable sales models with convenience, chain drug, mass market and supermarket retailers for neuenergy® and new novel ingredients for product distribution. The company also continues to develop emerging sales channels in the US, Europe and Asia. For more information, visit the company’s website at www.NeutriSci.com.


\
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist